Squarepoint
TMCI icon

Squarepoint’s Treace Medical Concepts TMCI Stock Holding History

Squarepoint’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$194K Sell
43,776
-27,025
-38% -$121K ﹤0.01% 4075
2026
Q2 		$282K Buy
+70,801
New +$195K ﹤0.01% 3855
2025
Q4 		– Sell
-28,988
Closed -$195K – 4893
2025
Q3 		$195K Sell
28,988
-19,984
-41% -$130K ﹤0.01% 3958
2025
Q2 		$288K Buy
+48,972
New +$319K ﹤0.01% 3725
2025
Q1 		– Sell
-18,470
Closed -$137K – 5414
2024
Q4 		$137K Sell
18,470
-52,890
-74% -$354K ﹤0.01% 4607
2024
Q3 		$414K Sell
71,360
-46,687
-40% -$300K ﹤0.01% 3241
2024
Q2 		$785K Buy
118,047
+88,577
+301% +$716K ﹤0.01% 2738
2024
Q1 		$385K Sell
29,470
-100,800
-77% -$1.34M ﹤0.01% 3224
2023
Q4 		$1.66M Buy
130,270
+13,476
+12% +$136K ﹤0.01% 2141
2023
Q3 		$1.53M Buy
116,794
+99,359
+570% +$1.82M ﹤0.01% 2020
2023
Q2 		$446K Sell
17,435
-46,399
-73% -$1.2M ﹤0.01% 2690
2023
Q1 		$1.61M Buy
63,834
+13,679
+27% +$321K 0.01% 1566
2022
Q4 		$1.15M Buy
+50,155
New +$1.15M ﹤0.01% 1729

Other funds holding TMCI

Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Weber Capital Management
Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LS
LCW Services Virginia Beach, Virginia $240M AUM 12.93% 1-Year Est. Return

Squarepoint's TMCI Position: Q3 2026 in Review

Squarepoint reduced its Treace Medical Concepts (TMCI) stake by 38% in Q3 2026, selling an estimated $121K and leaving 43,776 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #4075.

Squarepoint first reported a position in TMCI in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.66M in Q4 2023. 69 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Squarepoint held 43,776 shares of Treace Medical Concepts worth $194K as of Q3 2026.
  • Squarepoint sold 27,025 Treace Medical Concepts shares in Q3 2026, an estimated $121K.
  • Treace Medical Concepts made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4075 holding.
  • Squarepoint first reported a position in Treace Medical Concepts in Q4 2022 and has held it in 13 quarters since.
  • Squarepoint's Treace Medical Concepts position peaked at $1.66M in Q4 2023.
  • 69 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.